2004•PubMedRequires access

[Radiofrequency ablation in primary and metastatic hepatic tumors].

Sławomir Rudzki, Adam Jamroz

Open publisher page 0 citations

Abstract

A number of alternative therapies have been used for the treatment of malignant hepatic tumors. Radiofrequency ablation (RFA) is an evolving technology being used to treat patients with unresectable primary and metastatic hepatic cancers. RFA produces coagulative necrosis of the tumor through local tissue heating. Liver tumors can be treated percutaneously, laparoscopically, or during laparotomy, using ultrasonography to identify tumors and to guide placement of the RFA needle electrode. In general, RFA is a safe, well-tolerated, effective treatment for unresectable hepatic malignancies less than 6.0 cm in diameter.

About this research paper

What this paper is about

A number of alternative therapies have been used for the treatment of malignant hepatic tumors. Radiofrequency ablation (RFA) is an evolving technology being used to treat patients with unresectable primary and metastatic hepatic cancers. RFA produces coagulative necrosis of the tumor through local tissue heating. Liver tumors can be treated percutaneously, laparoscopically, or during laparotomy, using ultrasonography to identify tumors and to guide placement of the RFA needle electrode. In general, RFA is a safe, well-tolerated, effective treatment for unresectable hepatic malignancies less than 6.0 cm in diameter.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A number of alternative therapies have been used for the treatment of malignant hepatic tumors. Radiofrequency ablation (RFA) is an evolving technology being used to treat patients with unresectable primary and metastatic hepatic cancers. RFA produces coagulative necrosis of the tumor through local tissue heating. Liver tumors can be treated percutaneously, laparoscopically, or during laparotomy, using ultrasonography to identify tumors and to guide placement of the RFA needle electrode. In general, RFA is a safe, well-tolerated, effective treatment for unresectable hepatic malignancies less than 6.0 cm in diameter.

Key concepts: Coagulative necrosis, Radiofrequency ablation, Medicine, Laparotomy, Ablation, Radiology, Hepatic tumor, Ultrasonography

Related papers

Back to paper searchBrowse research topicsOriginal source
[Radiofrequency ablation in primary and metastatic hepatic tumors]. — Research Paper | ScholarLens